Physician profile
Alexa Mcghee
NPI 1598544892
$3,950.58
in general payments reported to CMS, 2019-2025
20 companies · $2,777 in 2025
The $2,777 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,174 · 2025: $2,777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,708 · Education: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,707.61 |
| Education | $242.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $950.29 | 2024-2025 | Tremfya |
| Abbvie INC. | $784.39 | 2024-2025 | |
| Incyte Corporation | $450.25 | 2024-2025 | Opzelura, Opzelura |
| Sun Pharmaceutical Industries INC. | $442.45 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $241.66 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $212.49 | 2024-2025 | Zoryve |
| Botanix Sb INC | $124.45 | 2025 | Sofdra |
| Lilly USA, LLC | $113.88 | 2024-2025 | Ebglyss, Taltz |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $110.49 | 2024-2025 | Cabtreo, Jublia, Siliq |
| Regeneron Healthcare Solutions, INC. | $92.27 | 2024-2025 | Libtayo, Dupixent |
| Novartis Pharmaceuticals Corporation | $79.65 | 2025 | |
| Genzyme Corporation | $68.50 | 2024-2025 | |
| Galderma Laboratories, L.P. | $57.45 | 2025 | Nemluvio |
| Polynovo North America LLC | $50.48 | 2024 | Novosorb Btm |
| Leo Pharma INC. | $41.60 | 2025 | Anzupgo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $31.93 | 2025 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $28.64 | 2025 | Sotyktu |
| Pfizer INC. | $28.09 | 2025 | |
| Ucb, INC. | $27.44 | 2025 | Bimzelx |
| Almirall LLC | $14.18 | 2025 | Seysara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Mcghee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.